Home > Healthcare > Medical Devices > Implantable Devices > Implantable Medical Devices Market

Implantable Medical Devices Market Share

  • Report ID: GMI4483
  • Published Date: Mar 2023
  • Report Format: PDF

Implantable Medical Devices Market Share

Some key players in the implantable medical devices market are

  • AbbVie Inc. (Allergan plc)
  • Zimmer Biomet
  • MicroPort Scientific Corporation
  • Henry Schein, Inc.
  • Smith & Nephew plc
  • Stryker Corporation
  • Medtronic
  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Alcon Laboratories
  • Mindray Medical International Limited
  • Bausch & Lomb
  • POLYTECH Health & Aesthetics
  • Demant A/S
  • MED-EL GmbH
  • Advanced Bionics Corporation (Sonova Holdings AG)
  • W. L. Gore & Associates, Inc.
  • Cochlear Limited
  • Johnson & Johnson
  • BIOTRONIK SE & Co. KG.

These companies majorly engage in product innovation and customer base expansion tactics to stay ahead in the competitive landscape. For instance, in May 2022, Johnson & Johnson, a pharmaceutical firm, announced that its medical devices subsidiary, DePuy Synthes, received the U.S. FDA 510(k) clearance for INHANCE Shoulder Implant System. This allowed the company to efficiently enhance its market presence and obtain a competitive advantage.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for implantable medical devices was valued at more than USD 112.5 billion in 2022 and is set to progress at over 9% CAGR between 2023 and 2032 owing to advancements of disease management services for early diagnosis and disease detection.

The ambulatory surgical centers application segment accounted for over USD 19 billion in 2022 due to the mounting number of patients visiting ambulatory surgical centers for different interventional surgeries.

Static/non-active/passive segment is projected to depict more than 8% CAGR over 2023-2032 as a result of the low requirement for external power supply compared to its counterpart.

Europe implantable medical devices market valuation is foreseen to reach over USD 63.5 billion by 2032 on account of an upsurge in cardiovascular disorder instances and the increasing number of surgeries being performed resulting in extensive demand for pacemakers and implantable cardioverter defibrillators in the region.

Implantable Medical Devices Market Scope

Buy Now

Immediate Delivery Available

Premium Report Details

  • Base Year: 2022
  • Companies covered: 20
  • Tables & Figures: 859
  • Countries covered: 33
  • Pages: 492
 Download Free Sample